Congenital anomalies · 2018
Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Terasawa Sumire, Kato Asuka, Nishizawa Haruki, Kato Takema, Yoshizawa Hikari, Noda Yoshiteru, Miyazaki Jun, Ito Mayuko, Sekiya Takao, Fujii Takuma, Kurahashi Hiroki
Аннотация
Thanatophoric dysplasia and achondroplasia are allelic disorders caused by a constitutively active mutation in the FGFR3 gene. Because thanatophoric dysplasia is a lethal disorder and achondroplasia is non-lethal, they need to be distinguished after ultrasound identification of fetal growth retardation with short limbs. Accordingly, we have developed a noninvasive prenatal test using cell-free fetal DNA in the maternal circulation to distinguish thanatophoric dysplasia and achondroplasia. A multiplex PCR system encompassing five mutation hotspots in the FGFR3 gene allowed us to efficiently identify the responsible mutation in cell-free DNA in all examined pregnancies with a suspected thanatophoric dysplasia or achondroplasia fetus. This system will be helpful in the differential diagnosis of thanatophoric dysplasia and achondroplasia in early gestation and in couples concerned about the recurrence of thanatophoric dysplasia due to germinal mosaicism.
Предметные рубрики MeSH
AchondroplasiaAdultBase SequenceBiomarkersCell-Free Nucleic AcidsDiagnosis, DifferentialFemaleFetal Growth RetardationFetusGene ExpressionHumansMosaicismMultiplex Polymerase Chain ReactionMutationPregnancyPregnancy Trimester, SecondPregnancy Trimester, ThirdPrenatal DiagnosisReceptor, Fibroblast Growth Factor, Type 3Thanatophoric DysplasiaTomography, X-Ray ComputedUltrasonography